Stock listing

Myriad Genetics, Inc.

Selected listing: 0K3W · LSE · USD · GB

Myriad Genetics, Inc. (LSE:0K3W), Health Technology. Latest release Sep 16, 2026: Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial.

0K3W:LSEUSDGBUpdated October 2, 2026

Ticker: LSE:0K3W
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: LSE
Currency: USD

About Myriad Genetics, Inc.

The company specializes in genetic testing and precision medicine, providing insights that help in the diagnosis and treatment of various health conditions. Myriad focuses on advancing healthcare through innovative genetic solutions.

Latest news from Myriad Genetics, Inc.

Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial

September 16, 2026

Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference

August 27, 2026

Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability

July 30, 2026

Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026

July 23, 2026

Myriad Genetics Launches FirstGene® Multiple Prenatal Screen

July 21, 2026

All Myriad Genetics, Inc. news →

Events

Replays

Myriad Genetics, Inc. (MYGN) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 04:30 PM ET
Watch
Myriad Genetics, Inc. (MYGN) Q1 2026 Earnings Call
Tue, May 05, 2026 · 04:30 PM ET
Watch
Myriad Genetics, Inc. (MYGN) Q4 2025 Earnings Call
Mon, Feb 23, 2026 · 04:30 PM ET
Watch

Research Myriad Genetics, Inc.

Myriad Genetics, Inc. company profile

View the public company page for Myriad Genetics, Inc. on 6ix.

Myriad Genetics, Inc. news

Read company news and market updates connected to Myriad Genetics, Inc..

Myriad Genetics, Inc. investor events

Find investor webinars, events, and replay context for Myriad Genetics, Inc..